Wyo. Code R. 059-0001-15
Pharmacy, Board of
Chapter 15: Long Term Care Pharmacy Services
Effective Date: 12/13/2005 to 01/16/2014
Rule Type: Superceded Rules & Regulations
Reference Number: 059.0001.15.12132005
These regulations are promulgated as authorized by the Act.
(a) 'Long Term Care Facility' means any skilled or intermediate care nursing home, board and care home, or any patient behavioral health facility subject to regulation and licensure by the department of health. For the purpose of this chapter, long term care facility does not include adult day care facilities, home health agencies, or assisted living facilities.
(b) 'Consultant Pharmacist' in a long-term facility means a pharmacist licensed to engage in the practice of pharmacy in this state who is responsible for developing, coordinating, and supervising pharmaceutical services in a long-term care facility on a regularly scheduled basis.
(c) 'Medication Order' as used in these rules, means a written order from a practitioner or an oral order from a practitioner or the practitioner's authorized agent for administration of a drug or device. For purposes of this chapter, a 'medication order' is considered a prescription.
(d) 'Provider pharmacy' means any pharmacy licensed by the board that provides medications to residents of any long-term care facility pursuant to a medication order or prescription.
Nothing in these rules shall be deemed to constitute a waiver or abrogation of any of the provisions of board rules or other applicable provisions of state and federal laws and rules, nor should these rules be construed as authorizing or permitting any person not licensed as a pharmacist to engage in the practice of pharmacy.
No consultant pharmacist or provider pharmacy shall participate in any agreement or plan that infringes on any resident's right to freedom of choice as to the provider of pharmacy services. A resident in a long-term care facility shall have a choice of a provider pharmacy provided the provider pharmacy complies with the Section 4 of this chapter.
A provider pharmacy shall be responsible for:
(a) Dispensing drugs pursuant to a medication order for an individual resident, properly labeled for that resident, as addressed in Chapter 2, Section 11 of the board's rules.
(b) Dispensing drugs for residents of long-term care facilities in packaging consistent with the drug distribution system required by the facility's policies and procedures.
(c) Developing a drug recall procedure that protects the health and safety of residents including immediate discontinuation of any recalled drug or device and subsequent notification of the prescriber and director of nursing of the facility.
(d) Providing a 24-hour emergency service either directly or by contract with another pharmacy.
(e) Performing prospective drug usage reviews for all new and refill medication orders as described in Chapter 9, Section 4 of the board's rules.
(f) Providing sufficient and accurate information to facility staff regarding the appropriate administration and use of all dispensed drugs and devices.
(g) Communicating with the consultant pharmacist and the facility regarding concerns and resolution thereof.
(a) The consultant pharmacist shall assist the long-term facility in developing policy and procedures for the following:
(i) Manner of issuance of prescription drugs provided by a provider pharmacy to residents of the long-term care facility.
(ii) Storage, administration, and record-keeping for all medications administered to residents of the long-term care facility.
(iii) Inspection of drug storage areas.
(iv) Destruction or recycling of unused patient medication.
(v) Continuing education for nursing personnel regarding medication administration.
(b) Patient Drug Regimen Review.
(i) The primary duty of the consultant pharmacist is to apply his/her expertise on drugs to the patients' specific situation.
(ii) State and federal regulations shall be the minimum standards for an adequate drug regimen review.
(iii) The consultant pharmacist shall review each patient's chart at least monthly and:
(A) Ascertain that patient history and drug utilization is being properly recorded.
(B) Review drug usage, including both prescriptions and O.T.C.'s.
(C) Review patient compliance with drug regimen.
(D) Review drug allergies or sensitivities.
(E) Determine whether the patient is predisposed to side effects due to disease, illness, or age.
(F) Determine whether potential exists for significant drug interaction.
(G) Monitor patients' records for signs that indicate abuse or misuse of drugs by the patient or other individuals.
(H) Make recommendations regarding drug therapy to the physician.
(I) The consultant pharmacist shall communicate with provider pharmacies to enhance patient care.